Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LBTYA | 8-K | neutral | 2/10 | Liberty Global filed an 8-K announcing it will present at the Morgan Stanley European Technology, Media & Telecom Confer | Oct 28, 2026 |
| GERN | 8-K | bearish | 6/10 | Geron announced the discontinuation of its Phase 3 IMpactMF trial of imetelstat in relapsed/refractory myelofibrosis aft | Oct 28, 2026 |
| DBVT | PRESS-RELEASE | neutral | 6/10 | DBV Technologies reported Q3 2026 net loss of $64.5M ($0.14 per share), wider than the $33.2M loss in Q3 2025, as R&D an | Oct 28, 2026 |
| OPCH | PREM14A | bullish | 7/10 | Option Care Health filed a preliminary proxy statement (PREM14A) for a special meeting to approve its acquisition by an | Oct 28, 2026 |
| MG | DEFA14A | neutral | 5/10 | Mistras Group filed this DEFA14A to announce the expiration of the 40-day go-shop period under its merger agreement with | Oct 28, 2026 |
| TMO | 144 | neutral | 2/10 | Lisa Britt, an officer of Thermo Fisher Scientific, filed a Form 144 notice of intent to sell shares. The filing covers | Oct 28, 2026 |
| MG | 8-K | neutral | 5/10 | Mistras Group announced the expiration of the 40-day go-shop period under its merger agreement with H.I.G. Capital. No a | Oct 28, 2026 |
| RDN | 8-K | neutral | 2/10 | Radian Group appointed Daniel Kobell as Senior Executive Vice President and permanent Chief Financial Officer, formalizi | Oct 28, 2026 |
| AXS | 8-K | bearish | 5/10 | AXIS Capital reported Q3 2026 net income available to common shareholders of $202M ($2.75 per diluted share), down 32% f | Oct 28, 2026 |
| CASH | 144 | neutral | 3/10 | Anthony M. Sharett, an officer of Pathward Financial, filed a Form 144 notice of intent to sell 20,000 shares of common | Oct 28, 2026 |
| CMP | 8-K | neutral | 2/10 | Compass Minerals disclosed the resignation of Chief Accounting Officer Ashley Ward (effective October 23, 2026) and the | Oct 28, 2026 |
| DAR | 8-K | bullish | 6/10 | Darling Ingredients reported Q3 2026 GAAP diluted EPS of $1.67 on total net sales of $1.79 billion, compared to $0.12 an | Oct 28, 2026 |
| MKL | PRESS-RELEASE | bullish | 6/10 | Markel Group reported Q3 2026 operating revenues of $4.16B, up 6% YoY, and adjusted operating income of $707M, up 14% Yo | Oct 28, 2026 |
| AYI | 144 | neutral | 3/10 | Neil Ashe, an officer of Acuity Inc., filed a Form 144 notice of intent to sell 22,060 shares of common stock, with an a | Oct 28, 2026 |
| BLCO | 8-K | neutral | 2/10 | Director Nathalie Bernier resigned from the Bausch + Lomb board and its Science and Technology Committee, effective Octo | Oct 28, 2026 |
| ILXP | 8-K | neutral | 3/10 | Ecominas Corp. terminated an Asset Purchase Agreement to acquire technology and real-property assets from a seller who b | Oct 28, 2026 |
| SCI | 8-K | bearish | 6/10 | SCI reported Q3 2026 adjusted EPS of $0.97, missing the consensus estimate of $0.99 by 2.0%, while revenue of $1.107B sl | Oct 28, 2026 |
| MORN | 8-K | bullish | 6/10 | Morningstar reported Q3 2026 revenue of $672.1M (+8.9% YoY, +6.8% organic) and diluted EPS of $3.06 (+41.0% YoY), both a | Oct 28, 2026 |
| IBEX | DEF 14A | neutral | 4/10 | IBEX Ltd filed its definitive proxy statement for the 2026 annual meeting, seeking shareholder approval for eight propos | Oct 28, 2026 |
| OBT | 8-K | bullish | 6/10 | Orange County Bancorp reported record Q3 2026 net income of $12.5M ($0.93 EPS), up 24.6% from $10.0M ($0.75 EPS) a year | Oct 28, 2026 |
| CREX | SC 13G/A | neutral | 2/10 | Mink Brook Asset Management LLC filed Amendment No. 5 to its Schedule 13G, reporting aggregate beneficial ownership of 1 | Oct 28, 2026 |
| GLOO | SC 13G/A | neutral | 2/10 | Thrivent Financial for Lutherans filed an amended Schedule 13G disclosing a 7.7% passive stake in Gloo Holdings as of Se | Oct 28, 2026 |
| KMTS | 144 | neutral | 3/10 | Mahboob Vaseem, an officer of Kestra Medical Technologies, filed a Form 144 notice of intent to sell 39,903 shares of co | Oct 28, 2026 |
| BNC | DEF 14A | neutral | 5/10 | BNB Standard Corp is holding a special meeting to seek stockholder approval for two equity incentive plans. The 2025 Pla | Oct 28, 2026 |
| ROIV | 144 | neutral | 3/10 | Eric Venker, an officer of Roivant Sciences, filed a Form 144 notice of intent to sell 200,000 common shares valued at a | Oct 28, 2026 |
| RNAZ | 8-K | neutral | 5/10 | TransCode Therapeutics announced that its board has initiated a formal strategic process to evaluate options for maximiz | Oct 28, 2026 |
| AIRS | SC 13G/A | neutral | 2/10 | Thrivent Financial for Lutherans and its affiliate Thrivent Investment Capital Advisors, LLC filed an amendment to Sched | Oct 28, 2026 |
| STRR | SC 13G/A | neutral | 2/10 | Mink Brook Partners LP and related entities filed Amendment No. 5 to their Schedule 13G, disclosing aggregate beneficial | Oct 28, 2026 |
| MSGR | 3 | neutral | 2/10 | Brian G. Sweeney filed an initial statement of beneficial ownership (Form 3) with MSG Rangers Corp. (formerly MSGS Spinc | Oct 28, 2026 |
| RBKB | SC 13G/A | neutral | 2/10 | M3 Partners LP filed an amended Schedule 13G disclosing a 3.88% passive stake in Rhinebeck Bancorp as of September 30, 2 | Oct 28, 2026 |